
Officials urge those who left school without lifesaving vaccine to get protected
The HPV vaccine is offered to boys and girls when they are in Year 8 and is key to wiping out cervical cancer in the UK.
Around 13 high-risk types of HPV are known to cause 99.7% of cervical cancers.
The jab also protects against genital warts and head and neck cancers, such as those in the mouth or throat.
Now, GP practices in England will invite 16 to 25-year-olds to have the vaccine if records show they did not have it in school.
According to NHS England, more than 418,000 children left school without having the jab in the last three years, with concerns there are many more people aged 16 to 25 who are not protected.
Dr Amanda Doyle, national director of primary care and community services, said: 'This vaccine is hugely important in our fight to eradicate cervical cancer but it isn't just for girls and women – it's also vital for boys and men to get vaccinated to protect themselves against cancers of the mouth, throat or genitals, while preventing spreading the HPV infection to sexual partners who could then develop cervical cancer.
'Too many lives are lost to cervical cancer so the hard work of NHS staff across the country in vaccinating and screening as many people as possible will help us to meet our ambition of wiping out this disease.
'Encouraging progress has been made recently in increasing uptake but we know there is much more to do.
'So if you're eligible for a HPV vaccination or are the parent of a child who is eligible, but didn't get the vaccine at school when they had the chance, I would urge you to come forward when your GP contacts you.
'Only a single dose is required and it could save you or your child's life.'
Data shows that in the 2023/24 academic year, some 76.7% of girls and 71.2% of boys aged 14 to 15 were vaccinated against HPV by Year 10.
Uptake in Year 8 increased to 72.9% among girls and 67.7% among boys, from 71.3% and 65.2% respectively a year earlier.
The health service will aim to boost uptake among girls to 90% as part of plans to eliminate cervical cancer by 2040.
It will also aim to increase the number of women attending cervical cancer screening appointments.
Public health minister Ashley Dalton said the vaccine 'is our most powerful tool in our fight to eliminate cervical cancer by 2040' but said there is a 'long way to go'.
'Thousands of young people are still unvaccinated and vulnerable to this disease – which is so easily prevented,' she added.
Last month, the UK Health Security Agency (UKHSA) warned young women in some parts of England are at greater risk of cervical cancer because not enough children are getting the jab.
Analysis by the agency showed inequalities in vaccine uptake in some regions – by Year 10, HPV coverage in girls was lowest in London (64.9%) and highest in the South East (82.7%).
Among boys, it was also lowest in London (58.9%) and highest in the South East (77.3%).
Meanwhile, at local authority level, Year 10 vaccination levels in girls ranged from 38.7% (Lambeth in London) to 97.6% (Northumberland).
Among boys, it ranged from 28.2% (Lambeth in London) to 92.2% (West Berkshire).
Dr Sharif Ismail, consultant epidemiologist at UKHSA, said: 'We know that uptake of the HPV vaccination in young people has fallen significantly since the pandemic, leaving many, many thousands across the country at greater risk of HPV-related cancers.
'This is a real concern as each HPV vaccine, now just a single dose offered in schools, gives a young person good protection against the devastating impact of these cancers, which includes cervical, genital, mouth and throat cancers.
'This new catch-up campaign is a really important opportunity for us to make sure that no teenage girl or boy, young woman or man is denied that protection.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scottish Sun
22 minutes ago
- Scottish Sun
Warning to fat jabs users as patients start pilling on pounds after treatment stops, research shows
The hunger signals fat jabs block can start up again once the treatment ends FAT IS BACK Warning to fat jabs users as patients start pilling on pounds after treatment stops, research shows PEOPLE on weight-loss jabs start piling the flab back on just two months after they stop taking them, research shows. The drugs work well for those who have failed other methods or are very large. However, the hunger signals they block can start up again once the treatment ends. A review of 11 studies covering more than 2,000 slimmers found they kept the weight off for at least four weeks after stopping, but started putting it back on by the eight-week mark. And their weight gain tended to continue for five months before it stabilised. Patients who took popular fat jab Mounjaro regained almost half the weight they had lost while on the drug. Study author Dr Xiaoling Cai, from Peking University People's Hospital in China, said: 'Weight regain is common, so it is necessary to establish long-term anti-obesity treatment.' Katherine Jenner, director of Britain's Obesity Health Alliance, said: 'This underlines why we can't medicate ourselves out of the obesity crisis. "Without tackling the root causes, people are left swimming against the tide.' A separate study at Oxford University suggested many fat jab patients regain all the weight they lose within two years of stopping medication. NHS prescriptions for jabs like Wegovy and Mounjaro hit 2.7million in England last year — and more people are buying privately, potentially missing out on diet and lifestyle advice. I've lost nearly 6 stone in 9 months on fat jabs - trolls call me 'lazy' & say it's the 'easy way out' but I don't care


Glasgow Times
22 minutes ago
- Glasgow Times
Government pledges to ‘transform care' for people with ME
The Department of Health and Social Care said it is 'committed to changing attitudes and transforming care' for people with Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) as it prepared to publish a new plan to improve care for people with the condition. It comes after the high-profile death of a young woman from the disease. Public health minister Ashley Dalton said the plan will 'help tackle the stigma and lack of awareness of this condition' (Peter Byrne/PA) Maeve Boothby-O'Neill, 27, suffered with ME for a decade before she died at home in Exeter in October 2021 from severe malnutrition. Her inquest heard how she had been admitted to the Royal Devon and Exeter Hospital three times that year for treatment for malnutrition. The 10-day hearing focused on the final few months of her life, by which time she was confined to bed, unable to chew food and had difficulty drinking because she was not able to sit up. Miss Boothby-O'Neill, the daughter of Sean O'Neill, a journalist with The Times newspaper, had been suffering from fatigue since the age of 13, which got worse after she completed her A-levels. Deborah Archer, now an area coroner for Devon, Plymouth and Torbay, concluded Miss Boothby-O'Neill had died from natural causes 'because of severe myalgic encephalomyelitis (ME)'. Last year she wrote to the Government to highlight a lack of specialist beds, 'extremely limited' training for doctors and lack of available funding for research and treatment of the condition. On Tuesday, the Government said that it has created a plan which 'outlines clear steps to improve care for patients, by investing in research and offering access to care in the community'. The Department of Health and Social Care (DHSC) acknowledged that many people with the condition 'currently struggle to access appropriate care tailored to their complex condition'. The plan, which is expected to be published on Tuesday, will include new training for NHS workers, DHSC said. And the document will also include funding for research, the DHSC said. Public health minister Ashley Dalton, said: 'ME/CFS is a debilitating illness that can severely limit patients' ability to participate in everyday activities, maintain employment, or enjoy family and social life. 'Today's plan will help tackle the stigma and lack of awareness of this condition through improved training for NHS staff. 'And through our neighbourhood health services, we will ensure patients suffering from the effects of ME/CFS can access quality care, closer to home, as pledged in our 10-Year Health Plan. But Action for ME said that the plan 'does not go far enough'. Sonya Chowdhury, chief executive of the charity, said: 'We appreciate the time DHSC has put into the delivery plan and their engagement with us and the ME community throughout. 'However, the plan simply does not go far enough. We are at the stage now where we need more than rhetoric, we need to take a strategic approach if we want a different outcome. What is proposed in the plan will not offer this. 'We must have a funded, dedicated research hub to leverage our world-leading life sciences sector to unlock treatments and ultimately cures for ME. 'Without a commitment to better co-ordinate research, people with ME will continue to be neglected, overlooked and, for many, confined to their homes. 'ME charities have been calling for this funding to be accelerated for years and we are still not seeing a strategic approach to address this historic shortfall. Once again, it feels like people with ME have been ignored.' Dr Charles Shepherd, honorary medical advisor and trustee at the ME Association, said: 'Whilst today's announcement is an important step forward in helping to improve the quality of life of people with ME/CFS, the Government must now go much further to improve their medical care and management and help to fund much needed biomedical research into cause and treatment.'


The Sun
22 minutes ago
- The Sun
Warning to fat jabs users as patients start pilling on pounds after treatment stops, research shows
PEOPLE on weight-loss jabs start piling the flab back on just two months after they stop taking them, research shows. The drugs work well for those who have failed other methods or are very large. However, the hunger signals they block can start up again once the treatment ends. A review of 11 studies covering more than 2,000 slimmers found they kept the weight off for at least four weeks after stopping, but started putting it back on by the eight-week mark. And their weight gain tended to continue for five months before it stabilised. Patients who took popular fat jab Mounjaro regained almost half the weight they had lost while on the drug. Study author Dr Xiaoling Cai, from Peking University People's Hospital in China, said: 'Weight regain is common, so it is necessary to establish long-term anti-obesity treatment.' Katherine Jenner, director of Britain's Obesity Health Alliance, said: 'This underlines why we can't medicate ourselves out of the obesity crisis. "Without tackling the root causes, people are left swimming against the tide.' A separate study at Oxford University suggested many fat jab patients regain all the weight they lose within two years of stopping medication. NHS prescriptions for jabs like Wegovy and Mounjaro hit 2.7million in England last year — and more people are buying privately, potentially missing out on diet and lifestyle advice. I've lost nearly 6 stone in 9 months on fat jabs - trolls call me 'lazy' & say it's the 'easy way out' but I don't care 1